Vashishth Ashish, Fulcheri Andrea, Prasad Sampath Chandra, Dandinarasaiah Manjunath, Caruso Antonio, Sanna Mario
Department of Otology and Skull Base Surgery, Gruppo Otologico, Piacenza, Rome, Italy.
Otol Neurotol. 2018 Jan;39(1):45-53. doi: 10.1097/MAO.0000000000001624.
To evaluate the long-term surgical outcomes of cochlear implantation (CI) in chronic otitis media (COM) with cholesteatoma and open cavities using subtotal petrosectomy (STP). To review device explantation (DE) patients and reimplantation considerations.
Retrospective review.
Otology and skull base center.
Charts of 35 patients (36 ears) with COM with cholesteatoma, including open cavities, who underwent CI were reviewed for surgical outcomes and DE. Patient demographics, pathologies, previous surgeries, staging of implantation, salient intraoperative findings at the time of implantation and follow-up were evaluated. Details of patients with DE were evaluated for cause, operative findings, and reimplantation considerations.
Mean age of patients was 65.94 years. Nineteen open cavities, 11 primary cholesteatomas, 3 petrous bone cholesteatomas, and 3 atelectatic middle ears represented the pathologies with 31 patients of CI with concurrent STP and 5 patients where implantation was staged. The mean follow-up was 7.16 years ranging from 2 to 13 years. Four patients (11%) had DE due to extrusion and cavity infection with three reimplanted in same or contralateral ear. All explantations occurred within 24 months of primary implantation. No residual or recurrent cholesteatoma was observed in any of the patients during follow-up.
CI is feasible in COM with cholesteatoma and open cavities with the use of STP and single-stage implantation can be performed in the absence of purulence. Despite low risk of residual cholesteatoma post meticulous disease removal, risk of DE remains, particularly in open cavity patients, and is higher than standard implantation. Reimplantation is often possible with careful considerations.
评估使用颞骨次全切除术(STP)对慢性化脓性中耳炎(COM)伴胆脂瘤及开放腔隙患者进行人工耳蜗植入(CI)的长期手术效果。回顾设备取出(DE)患者及再次植入的相关考量因素。
回顾性研究。
耳科学与颅底中心。
回顾了35例(36耳)患有COM伴胆脂瘤(包括开放腔隙)并接受CI的患者的病历,以评估手术效果和设备取出情况。评估了患者的人口统计学特征、病理情况、既往手术史、植入分期、植入时及随访时的显著术中发现。对设备取出患者的详细情况进行了病因、手术发现及再次植入相关考量因素的评估。
患者的平均年龄为65.94岁。19例开放腔隙、11例原发性胆脂瘤、3例岩骨胆脂瘤和3例中耳萎缩代表了病理情况,其中31例CI患者同时进行了STP,5例患者分期植入。平均随访时间为7.16年,范围为2至13年。4例患者(11%)因电极脱出和腔隙感染而取出设备,其中3例在同侧或对侧耳再次植入。所有取出均发生在初次植入后的24个月内。随访期间未在任何患者中观察到残留或复发性胆脂瘤。
对于COM伴胆脂瘤及开放腔隙患者,使用STP进行CI是可行的,在无脓性分泌物的情况下可进行一期植入。尽管在仔细清除疾病后残留胆脂瘤的风险较低,但设备取出的风险仍然存在,特别是在开放腔隙患者中,且高于标准植入。经过仔细考虑,再次植入通常是可行的。